asshole.news
Updated Friday, September 18, 2026, 17:06 ET · 70 outlets
Aardvark Therapeutics accused of misleading investors on drug trial...
1 outletAardvark Therapeutics·TMX Newsfile
As the outlets wrote it
- TMX Newsfile: Robbins LLP is Investigating Allegations that Aardvark Therapeutics, Inc. Misled Investors Regarding the Viability and Efficacy of its Lead Drug Candidate ARD-101
From the Friday, September 18, 2026 edition · archive